Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center Experience

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-138528

Published: 2020

Journal Articles

Food Deserts Are Associated with Acute Care Utilization Among Preschool Children with Sickle Cell Disease

Hamda Khan, MA, Nariman Ammar, PhD, Jerlym S. Porter, PhD MPH, Juan Ding, PhD, Jeremie H. Estepp, MD, Jason R. Hodges, PhD MA, Arash Shaban-Nejad, PhD MPH, Winfred Wang, MD, James G Gurney, PhD, Guolian Kang, PhD, Robert Davis, MD MPH, Jane S. Hankins, MD MS

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-138802

Published: 2020

Journal Articles

Fetal Hemoglobin Mediates the Effect of Beta Globin Gene Polymorphisms on Neurocognitive Functioning in Sickle Cell Disease

Andrew M Heitzer, PhD, Jennifer Longoria, PhD, Evadnie Rampersaud, PhD, Sara Rashkin, PhD, Jeremie H. Estepp, MD, Victoria Okhomina, MS, Winfred Wang, MD, Darcy Raches, PhD, Brian Potter, PhD, Allison A. King, MDMPH,PhD, Guolian Kang, PhD, Jane S. Hankins, MD MS

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-137065

Published: 2020

Journal Articles

Transcranial Doppler Velocities Conversion Rate Based on Increasing Hemoglobin Concentration: Analysies from the SCCRIP Cohort Study

Jeremie H. Estepp, MD, Ze Cong, PhD, Irene Agodoa, MD, Guolian Kang, PhD, Juan Ding, PhD, M. Beth McCarville, MD, Jane S. Hankins, MD MS, Winfred Wang, MD

Blood (2019) 134 (Supplement_1): 1002.

https://doi.org/10.1182/blood-2019-131177

Published: 2019

Journal Articles

Longitudinal Effect of Hydroxyurea Therapy on Left Ventricular Diastolic Function in Sickle Cell Anemia

Parul Rai, MD, Guolian Kang, PhD, Ronak Naik, MD, Jason Goldberg, MD, Xiwen Zhao, MSPH, Kenneth I. Ataga, MD, Vijaya Joshi, MD, Jane S. Hankins, MD MS

Blood (2019) 134 (Supplement_1): 1006.

https://doi.org/10.1182/blood-2019-130905

Published: 2019

Journal Articles

Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing Phase I/II Clinical Study

Blood (2019) 134 (Supplement_1): 2058.

https://doi.org/10.1182/blood-2019-126746

Published: 2019

Journal Articles

Evaluation of Factors Influencing Health Literacy in Adolescents and Adults with Sickle Cell Disease

Nidhi Bhatt, MD, Cecelia Calhoun, MD, Jason R. Hodges, PhD MA, Chinonyelum Nwosu, Guolian Kang, PhD, Allison A. King, MD MPH, PhD, Xiwen Zhao, MSPH, Jane S. Hankins, MD MS

Blood (2019) 134 (Supplement_1): 2110.

https://doi.org/10.1182/blood-2019-130755

Published: 2019

Journal Articles

Progression of Central Nervous System Vasculopathy in Young Adults with Sickle Cell Anemia

Grace Champlin, MD, Scott Hwang, MD PhD, Guolian Kang, PhD, Juan Ding, PhD, Jeremie H. Estepp, MD, Kenneth I. Ataga, MD, Curtis L. Owens, MD, Justin Newman, MD, Lisa M. Jacola, PhD ABPP-CN, Allison A. King, MD MPH, PhD, Robert Davis, MD MPH, Winfred Wang, MD, Jane S. Hankins, MD MS

Blood (2019) 134 (Supplement_1): 2290.

https://doi.org/10.1182/blood-2019-129193

Published: 2019

Journal Articles

Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell Disease

Anjelica C. Saulsberry, BA, Marita Partanen, PhD, Jerlym S. Porter, PhD MPH, Pradeep S. B. Podila, PhD MS, Jason R. Hodges, PhD MA, Allison A. King, MD MPH, PhD, Winfred Wang, MD, Xiwen Zhao, MSPH, Guolian Kang, PhD, Lisa M. Jacola, PhD ABPP-CN, Jane S. Hankins, MD MS

Blood (2019) 134 (Supplement_1): 519.

https://doi.org/10.1182/blood-2019-121617

Published: 2019

Journal Articles

Sequential Infusion of Tcrαβ- and CD45RA-Depleted Haploidentical Progenitor Cells Is Safe and Allows for Rapid Immune Reconstitution in Pediatric Patients with Recurrent Hematological Malignancies

Ali Y Suliman, MD MSc, Ying Li, MD PhD, David Cullins, Amanda J Sooter, Janice Riberdy, PhD, Madden Renee, MD, Ewelina Mamcarz, MD, Amr Qudeimat, MD, Akshay Sharma, MBBS, Ashok Srinivasan, MD, Aimee Talleur, MD, Anusha Sunkara, MS, Guolian Kang, PhD, Stephen Gottschalk, MD, Brandon Triplett, MD

Blood (2018) 132 (Supplement 1): 4574.

https://doi.org/10.1182/blood-2018-99-110886

Published: 2018

Journal Articles

Precision Medicine for Sickle Cell Disease through Whole Genome Sequencing

Blood (2018) 132 (Supplement 1): 3641.

https://doi.org/10.1182/blood-2018-99-117606

Published: 2018

Journal Articles

Insulin-like Growth Factor Binding Protein-3 (IGFBP3) Induces Fetal Hemoglobin in Hematopoietic Stem and Progenitor Cells from Patients with Sickle Cell Anemia

Alireza Paikari, MD, Tian Mi, PhD, Yankai Zhang, PhD, Evadnie Rampersaud, PhD, Guolian Kang, PhD, Gang Wu, PhD, Jane S. Hankins, MD MS, Jeremie H. Estepp, MD, Pavel Sumazin, PhD, Mitchell J. Weiss, MD PhD, Vivien A Sheehan, MD PhD

Blood (2018) 132 (Supplement 1): 722.

https://doi.org/10.1182/blood-2018-99-115383

Published: 2018

Journal Articles

Caregiver Perceptions of Adolescent Self-Management Skills Predicts Higher Disease Knowledge Among Adolescents with SCD

Anjelica C Saulsberry, BS, Jason Hodges, PhD, Justin Williams, PhD, Megan Loew, MS, Sheila Anderson, RN, Audrey Cole, RN, Guolian Kang, PhD, Chen Li, MS, Robert Cronin, MD MS, Jerlym Porter, PhD MPH, Jane S Hankins, MD MS

Blood (2017) 130 (Supplement 1): 3350.

https://doi.org/10.1182/blood.V130.Suppl_1.3350.3350

Published: 2017

Journal Articles

Nfix Â Promotes Survival of Immature Hematopoietic Cells Via Regulation of C-Mpl

Trent Hall, BS, MS, Megan Walker, BS, MS, Miguel Ganuza Fernandez, PhD, Per Holmfeldt, PhD, Marie Bordas, Guolian Kang, PhD, Wenjian Bi, PhD, Lance Palmer, PhD, David Finkelstein, PhD, Shannon McKinney-Freeman, PhD

Blood (2017) 130 (Supplement 1): 2423.

https://doi.org/10.1182/blood.V130.Suppl_1.2423.2423

Published: 2017

Journal Articles

Effects of Hydroxyurea (HU) on Neurocognitive Performance in Children with Sickle Cell Disease: A Prospective Trial

Winfred Wang, MD, Jane Schreiber, PhD, Guolian Kang, PhD, Chen Li, MS, Jane S Hankins, MD MS, Jeremie H. Estepp, MD, Kathleen Helton, MD

Blood (2017) 130 (Supplement 1): 760.

https://doi.org/10.1182/blood.V130.Suppl_1.760.760

Published: 2017

Journal Articles

A Developmental Examination of Pain Among Youth with Sickle Cell Disease

Nicole M Alberts, PhD, Jane S Hankins, MD MS, Guolian Kang, PhD, Chen Li, MS, Jason Hodges, PhD, Martha Villavicencio, PhD, James L Klosky, PhD ABPP

Blood (2017) 130 (Supplement 1): 4722.

https://doi.org/10.1182/blood.V130.Suppl_1.4722.4722

Published: 2017

Journal Articles

Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the β-Globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production

Christina Abrams, MD, Joseph Moen, MS, Guolian Kang, PhD, Winfred C. Wang, MD, Jane Hankins, MD MS, Jeremie H. Estepp, MD

Blood (2016) 128 (22): 125.

https://doi.org/10.1182/blood.V128.22.125.125

Published: 2016

Journal Articles

Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea

Joana Marie Mack, MD, Pawel Wiczling, PhD, Joseph Moen, MS, Guolian Kang, PhD, Robert I. Liem, MD MS, Julie A. Panepinto, MD MSPH, Gregory Kearns, PharmD, PhD FCP, FAAP, Kathleen A Neville, MD MS, Jeremie H. Estepp, MD

Blood (2016) 128 (22): 1314.

https://doi.org/10.1182/blood.V128.22.1314.1314

Published: 2016

Journal Articles

Prognostic Factors for Hospitalization of Children with Sickle Cell Anemia Treated with Hydroxyurea at Maximum Tolerated Dose

Jeremie H. Estepp, MD, Qinlei T. Huang, MS, Winfred C. Wang, MD, Guolian Kang, PhD

Blood (2015) 126 (23): 2177.

https://doi.org/10.1182/blood.V126.23.2177.2177

Published: 2015

Journal Articles

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Brandon M. Triplett, MD, Bradley Muller, Guolian Kang, PhD, Shane J Cross, PharmD, Joseph Moen, Mari H Dallas, MD, Christine Hartford, MD, William E. Janssen, PhD, Ping Law, PhD, Ewelina K. Mamcarz, MD, David R Shook, MD, Ashok Srinivasan, MD, Randall T Hayden, MD, Wing Leung, MD PhD

Blood (2015) 126 (23): 624.

https://doi.org/10.1182/blood.V126.23.624.624

Published: 2015

NARROW

Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center Experience

Food Deserts Are Associated with Acute Care Utilization Among Preschool Children with Sickle Cell Disease

Fetal Hemoglobin Mediates the Effect of Beta Globin Gene Polymorphisms on Neurocognitive Functioning in Sickle Cell Disease

Transcranial Doppler Velocities Conversion Rate Based on Increasing Hemoglobin Concentration: Analysies from the SCCRIP Cohort Study

Longitudinal Effect of Hydroxyurea Therapy on Left Ventricular Diastolic Function in Sickle Cell Anemia

Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing Phase I/II Clinical Study

Evaluation of Factors Influencing Health Literacy in Adolescents and Adults with Sickle Cell Disease

Progression of Central Nervous System Vasculopathy in Young Adults with Sickle Cell Anemia

Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell Disease

Sequential Infusion of Tcrαβ- and CD45RA-Depleted Haploidentical Progenitor Cells Is Safe and Allows for Rapid Immune Reconstitution in Pediatric Patients with Recurrent Hematological Malignancies

Precision Medicine for Sickle Cell Disease through Whole Genome Sequencing

Insulin-like Growth Factor Binding Protein-3 (IGFBP3) Induces Fetal Hemoglobin in Hematopoietic Stem and Progenitor Cells from Patients with Sickle Cell Anemia

Caregiver Perceptions of Adolescent Self-Management Skills Predicts Higher Disease Knowledge Among Adolescents with SCD

Nfix Â Promotes Survival of Immature Hematopoietic Cells Via Regulation of C-Mpl

Effects of Hydroxyurea (HU) on Neurocognitive Performance in Children with Sickle Cell Disease: A Prospective Trial

A Developmental Examination of Pain Among Youth with Sickle Cell Disease

Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the β-Globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production

Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea

Prognostic Factors for Hospitalization of Children with Sickle Cell Anemia Treated with Hydroxyurea at Maximum Tolerated Dose

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only